Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration

BACKGROUND: Anti–vascular endothelial growth factor (anti-VEGF) agents have become the standard of care in neovascular age-related macular degeneration (nAMD). Despite generally excellent response rates to anti-VEGF therapy, some patients do not respond or may respond suboptimally. In the case of re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Ophthalmol
Hauptverfasser: Razavi, Sam, Kodjikian, Laurent, Giocanti-Aurégan, Audrey, Dufour, Ingrid, Souied, Eric
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7890834/
https://ncbi.nlm.nih.gov/pubmed/33596867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-021-01841-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge